# Amneal Pharmaceuticals, Inc.: Form 8-K, filed Jun 2, 2022

- Company: [Amneal Pharmaceuticals, Inc.](/companies/amrx.md) (CIK 1723128)
- Form: 8-K
- Filed: 2022-06-02
- Accepted by EDGAR: Jun 2, 2022, 17:24 ET
- Period: 2022-06-02
- Accession: 0001723128-22-000023
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1723128/000172312822000023/amrx-20220602.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1723128/000172312822000023/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 1.02: Termination of a material agreement
- Item 2.03: New direct financial obligation
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1723128/000172312822000023/amrx-20220602.htm

Filed Jun 2, 2022.
Source: SEC EDGAR, the filing index for accession 0001723128-22-000023. Last ingested by Listed: Nov 10, 2026, 02:45 ET. No prices; not investment advice.
